Abstract Background Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral
and bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

World is in the middle of the pandemic (COVID-19), caused by SARS-COV-2 virus, which is
a significant global health crisis after Spanish influenza in the beginning of 20th century …

Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

Background The COVID-19 pandemic is responsible for many hospitalizations in intensive
care units (ICU), with widespread use of invasive mechanical ventilation (IMV) which …

The primary objective of this multicenter, observational, retrospective study was to assess
the incidence rate of ventilator-associated pneumonia (VAP) in coronavirus disease 2019 …

Background Patients with severe COVID-19 have emerged as a population at high risk of
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not …

Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …

Abstract COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported
worldwide. However, basic epidemiological characteristics have not been well established …